Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Mankoff

Showing results (111-120 of 244) with videos related to

Pageof 25
Sort By:
IEEE Transactions on Radiation and Plasma Medical Sciences|November 23, 2020
Quantifying bias and precision of kinetic parameter estimation on the PennPET Explorer, a long axial field-of-view scannerVarsha Viswanath, Austin R Pantel, Margaret E Daube-Witherspoon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2003
SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differencesSylvain Beaulieu, Paul Kinahan, Jeffrey Tseng, et al.
Health Physics|August 5, 2024
Optimizing Regulatory Reviews for Clinical Protocols That Use Radiopharmaceuticals: Findings of the University of Pennsylvania Radiation Research Safety CommitteeSylvia S Rhodes, Janelle E Jesikiewicz, Nikhil Yegya-Raman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
Multiagent PET for risk characterization in sarcomaJanet F Eary, Jeanne M Link, Mark Muzi, et al.
Nuclear Medicine and Biology|October 11, 2011
Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancerLanell M Peterson, Brenda F Kurland, Jeanne M Link, et al.
Magnetic Resonance Imaging|July 17, 2012
Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trialsRobert K Doot, Tove Thompson, Benjamin E Greer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyondDavid A Mankoff, Janet F Eary, Jeanne M Link, et al.
Tomography (Ann Arbor, Mich.)|April 30, 2021
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.
The Journal of Urology|September 5, 2018
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE TrialGerald L Andriole, Lale Kostakoglu, Albert Chau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastasesRobert K Doot, Mark Muzi, Lanell M Peterson, et al.
Pageof 25

Showing results (111-120 of 244) with videos related to

Sort By:
Pageof 25
IEEE Transactions on Radiation and Plasma Medical Sciences|November 23, 2020
Quantifying bias and precision of kinetic parameter estimation on the PennPET Explorer, a long axial field-of-view scannerVarsha Viswanath, Austin R Pantel, Margaret E Daube-Witherspoon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2003
SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differencesSylvain Beaulieu, Paul Kinahan, Jeffrey Tseng, et al.
Health Physics|August 5, 2024
Optimizing Regulatory Reviews for Clinical Protocols That Use Radiopharmaceuticals: Findings of the University of Pennsylvania Radiation Research Safety CommitteeSylvia S Rhodes, Janelle E Jesikiewicz, Nikhil Yegya-Raman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
Multiagent PET for risk characterization in sarcomaJanet F Eary, Jeanne M Link, Mark Muzi, et al.
Nuclear Medicine and Biology|October 11, 2011
Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancerLanell M Peterson, Brenda F Kurland, Jeanne M Link, et al.
Magnetic Resonance Imaging|July 17, 2012
Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trialsRobert K Doot, Tove Thompson, Benjamin E Greer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyondDavid A Mankoff, Janet F Eary, Jeanne M Link, et al.
Tomography (Ann Arbor, Mich.)|April 30, 2021
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.
The Journal of Urology|September 5, 2018
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE TrialGerald L Andriole, Lale Kostakoglu, Albert Chau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastasesRobert K Doot, Mark Muzi, Lanell M Peterson, et al.
Pageof 25